This observational study aims to evaluate the association between sodium urate deposition volume and coronary atherosclerotic plaques in patients with foot gout using dual-energy CT (DECT) and coronary CTA. This study will explore imaging-based evidence for the progression and risk prediction of adverse cardiovascular events in patients with gout.
Aged ≥18 years, male or female
Clinically diagnosed with podagra
Having high-risk factors for cardiovascular disease
Complete clinical data available
Women who are preparing for pregnancy, pregnant or breastfeeding
Male and female subjects of reproductive age who are unable to take effective contraceptive measures
Patients who cannot or are unable to undergo CTA scans
Patients with severe heart diseases such as severe heart failure, severe heart valve disease and cardiomyopathy
Patients with podagra who have high-risk factors for cardiovascular disease
Case-only
Prospective
DECT;CCTA
Diagnostic testPerform DECT and CCTA examinations on the patient
Volume of sodium urate deposition and coronary artery plaque volume
Measurement of sodium urate deposition volume and coronary artery plaque volume in patients with foot gout.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
